In addition, intraventricular administration of α‐FMH, an irreversible inhibitor of histidine decarboxylase, along with H1R and H2R antagonists and H3R agonists, has been shown to enhance motor behavior in rats with PD [92]. This evidence concerns the gene HRH2 and Parkinson disease.